Gadd45a functions as a promoter or suppressor of breast cancer dependent on the oncogenic stress

Cancer Research

Volumn 70, Issue 23, 2010, Pages 9671-9681

  Tront, Jennifer S ^a   Huang, Yajue ^a   Fornace Jr , Albert A ^c   Hoffman, Barbara ^a,b   Liebermann, Dan A ^a,b  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TEMPLE UNIVERSITY   (United States)

^c GEORGETOWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; BRCA1 PROTEIN; GLYCOGEN SYNTHASE KINASE 3BETA; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 45; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 45A; MYC PROTEIN; PROTEIN P53; RAS PROTEIN; STRESS ACTIVATED PROTEIN KINASE; STROMELYSIN 2; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BREAST CARCINOGENESIS; CELLULAR STRESS RESPONSE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE FUNCTION; GENE TARGETING; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; SENESCENCE; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR GENE; TUMOR VASCULARIZATION;

ANIMALS; BETA CATENIN; BLOTTING, WESTERN; CELL CYCLE PROTEINS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, MYC; GLYCOGEN SYNTHASE KINASE 3; IMMUNOHISTOCHEMISTRY; MALE; MAMMARY NEOPLASMS, ANIMAL; MATRIX METALLOPROTEINASE 10; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; NEOVASCULARIZATION, PATHOLOGIC; NUCLEAR PROTEINS; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TUMOR BURDEN; TUMOR SUPPRESSOR PROTEINS;

EID: 78649974153     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-10-2177     Document Type: Article

References (28)

1. Fornace A, Jackman J, Hollander M, Hoffman-Liebermann B, Liebermann D. Genotoxic stress response genes and growth arrest genes: gadd, MyD, and other genes induced by treatments eliciting growth arrest. Ann N Y Acad Sci 1992;663:139-54.
2. Liebermann D, Hoffman B. MyD genes in negative growth control. Oncogene Rev 1998;17:3319-30.
3. Cretu A, Sha X, Tront J, Hoffman B, Liebermann D. Stress sensor Gadd45 genes as therapeutic targets in cancer. Cancer Ther 2009;7:268-76.
4. Zhang W, Bae I, Krishnaraju K, Azam N, Fan W, Smith W, et al. Molecular cloning and characterization of murine CR6-a MyD118/Gadd45 related gene. Oncogene 1999;18:4899-907.
5. Vairapandi M, Balliet A, Hoffman B, Liebermann D. Gadd45b and Gadd45g are cdc2/cyclinB1 kinase inhibitors with a role in S and G2/M cell cycle checkpoints induced by genotoxic stress. J Cell Physiol 2002;192:327-38. (Pubitemid 34827609)
6. Wang X, Zhan Q, Coursen J, Khan M, Kontny H, Yu L, et al. Gadd45 induction of a G2/M cell cycle checkpoint. Proc Natl Acad Sci U S A 1999;96:3706-11. (Pubitemid 29168974)
7. Vairapandi M, Balliet A, Hoffman B, Liebermann D. The differentiation primary response gene MyD118, related to Gadd45, encodes for a nuclear protein which interacts with PCNA and p21WAF1/CIP1. Oncogene 1996;12:2579-94. (Pubitemid 26237787)
8. Vairapandi M, Azam N, Balliet A, Hoffman B, Liebermann D. Characterization of MyD118, Gadd45 and PCNA interacting domains: PCNA impedes gadd mediated negative growth control. J Biol Chem 2000;275:16810-9.
9. DeSmaele E, Zazzeroni F, Papa S, Nguyen D, Jin R, Jones J, et al. Induction of Gadd45beta by NF-KappaB down regulates pro-apoptotic JNK signaling. Nature 2001;414:308-13.
10. Amanullah A, Azam N, Balliet A, Hollander C, Hoffman B, Fornace A, et al. Cell signaling: cell survival and a Gadd45-factor deficiency. Nature 2003;424:741-2.
11. Takakawa M, Saito H. A family of stress-inducible Gadd45-like proteins mediate activation of the stress-responsiveness MTK1/MEKK4/MAPKKK pathway. Cell 1998;95:521-30. (Pubitemid 28533308)
12. Barreto G, Schafer A, Marhold J, Stach D, Swaminathan SK, Handa V, et al. Gadd45a promotes epigenetic gene activation by repair-mediated DNA demethylation. Nature 2007;445:671-5. (Pubitemid 46232889)
13. Tront J, Hoffman B, Liebermann D. Gadd45a suppresses ras-driven mammary tumorigenesis by activation of JNK and p38 stress signaling resulting in apoptosis and senescence. Cancer Res 2006;17:8448-54. (Pubitemid 44449156)
14. Adhikary S, Martin E. Transcriptional regulation and transformation by Myc proteins. Nat Rev Mol Cell Bio 2005;6:635-45. (Pubitemid 41081267)
15. Ernberg I. Oncogenes and tumor growth factors in breast cancer. A minireview. Acta Oncol 1990;29:331-4. (Pubitemid 20201961)
16. Jamerson MH, Johnson MD, Dickson RB. Of mice and Myc: c-Myc and mammary tumorigenesis. J Mammary Gland Biol Neoplasia 2004;9:27-37.
17. Sinn E, Muller W, Pattengale P, Tepler I, Wallace R, Leder P. Coexpression of MMTV/v-Ha-ras and MMTV/c-myc genes in transgenic mice: synergistic action of oncogenes in vivo. Cell 1987;49:465-75. (Pubitemid 18091823)
18. Chen Z, Trotman L, Shaffer D, Lin H, Dotan Z, Niki M, et al. Crucial role of p-53 dependent cellular senescence in suppression of Pten-deficient tumorigenesis. Nature 2005;436:725-30. (Pubitemid 41117277)
19. Braig M, Lee S, Loddenkemper C, Rudolph C, Peters A, Schlegelberger H, et al. Oncogene-induced senescence as an initial barrier in lymphoma development. Nature 2005;436:660-5. (Pubitemid 41117262)
20. Michaloglou C, Vredeveld L, Soengas M, Denoyelle C, Kuilman T, Van Der Horst C, et al. BRAFE600-associated senescence-like cell cycle arrest of human naevi. Nature 2005;436:720-30.
21. Saunders W, Bayless K, Davis G. MMP-1 activation by serine proteases and MMP-10 induces human capillary tubular network collapse and regression in 3D collagen matrices. J Cell Sci 2005;118:2325-40. (Pubitemid 40872853)
22. Woodfin A, Voisin MB, Nourshargh S. PECAM-1: a multi-functional molecule in inflammation and vascular biology. Arterioscler Thromb Vasc Biol 2007;27:2514-23. (Pubitemid 350158900)
23. Burrows FJ, Derbyshire EJ, Tazzari PL, Amlot P, Gazdar AF, King SW, et al. Up-regulation of endoglin on vascular endothelial cells in human solid tumors: implications for diagnosis and therapy. Clin Cancer Res 1995;12:1623-34. (Pubitemid 26030991)
24. Crawford HC, Fingleton BM, Rudolph-Owen LA, Goss KJ, Rubinfeld B, Polakis P, et al. The metalloproteinase matrilysin is a target of β-catenin transactivation in intestinal tumors. Oncogene 1999;18:2883-91. (Pubitemid 29250878)
25. Hart MJ, de los Santos R, Albert IN, Rubinfeld B, Polakis P. Downregulation of β-catenin by human Axin and its association with the APC tumor suppressor, b-catenin and GSK3 beta. Curr Biol 1998;8:57-81.
26. Hildesheim J, Belova G, Tyner S, Zhou X, Vardanian L, Fornace A. Gadd45a regulates matrix metalloproteinases by suppressing DNp63a and beta-catenin via p38 MAP kinase and APC complex activation. Oncogene 2004;23:1829-37. (Pubitemid 38445408)
27. Iwasa H, Han J, Ishikawa F. Mitogen-actived protein kinase p38 defines the common senescence-signaling pathway. Genes Cells 2003;8:131-44. (Pubitemid 36511698)
28. Bearss D, Lee R, Troyer D, Pestell R, Windle J. Differential effects of p21WAF1/CIP1 deficiency on MMTV-ras and MMTV-myc mammary tumor properties. Can Res 2002;62:2077-84. (Pubitemid 34408455)